Darras J, Joniau S, Van Poppel H
Department of Urology, University Hospital Leuven, Herestraat 49, 3000 Leuven, Belgium.
Eur J Surg Oncol. 2006 Nov;32(9):964-9. doi: 10.1016/j.ejso.2006.05.015. Epub 2006 Jul 11.
A rise in the incidence of radiorecurrent prostate cancer is to be expected, since approximately one third of early prostate cancer cases are nowadays treated with a radiotherapy modality. One possibility in treating radiorecurrent prostate cancer is salvage prostatectomy. Our objective was to look into our own experience with salvage radical prostatectomy and to analyse outcome and morbidity.
A computer search through our hospital database identified 11 patients who underwent a salvage radical prostatectomy for radiorecurrent cancer over the last 15 years. All data were retrospectively analysed and confronted with the literature.
Although the surgery was mostly difficult, there were no intraoperative complications. Bladder neck stricture is the most common postoperative complication (18%). Continence rates are worse than in classical radical prostatectomy. All patients lost potency, since no attempt was made to spare the neurovascular bundles. With a mean follow-up of 6.9 years, biochemical disease-free survival rates was 55%, while overall and cancer-specific survival was 91%.
While most patients with radiorecurrent prostate cancer will be treated by many experts with hormonal therapy, a salvage radical prostatectomy can give a second chance for cure in carefully selected patients.
鉴于目前约三分之一的早期前列腺癌病例采用放射治疗方式,放射性复发前列腺癌的发病率预计将会上升。治疗放射性复发前列腺癌的一种可能性是挽救性前列腺切除术。我们的目的是研究我们自己进行挽救性根治性前列腺切除术的经验,并分析其结果和发病率。
通过对我院数据库进行计算机检索,确定了过去15年中因放射性复发癌症接受挽救性根治性前列腺切除术的11例患者。所有数据均进行回顾性分析,并与文献进行对照。
尽管手术大多困难,但未发生术中并发症。膀胱颈狭窄是最常见的术后并发症(18%)。控尿率比经典根治性前列腺切除术更差。所有患者均失去性功能,因为未尝试保留神经血管束。平均随访6.9年,无生化疾病生存率为55%,而总生存率和癌症特异性生存率为91%。
虽然大多数放射性复发前列腺癌患者会由许多专家采用激素治疗,但挽救性根治性前列腺切除术可以为精心挑选的患者提供二次治愈机会。